Not available at the moment <a href="http://katkov.dev/price-of-priligy-in-pakistan-d944"></a> Despite only treating a few thousand patients worldwide,sales of Alexion's rare blood disease drug Solaris are forecastby analysts to reach $1.5 billion this year. Citi analystsforecast peak sales for Alexion of $6 billion in 2025.